Currently out of the existing stock ratings of Faisal Khurshid, 21 are a BUY (77.78%), 6 are a HOLD (22.22%).

Faisal Khurshid

Work Performance Price Targets & Ratings Chart

Analyst Faisal Khurshid, currently employed at LEERINK, carries an average stock price target met ratio of 76.39% that have a potential upside of 42.4% achieved within 115 days.

Faisal Khurshid’s has documented 54 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 19-Mar-2026.

Wall Street Analyst Faisal Khurshid

Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 7/7/2025. The price target of $88 was fulfilled within 2 days with a profit of $21.61 (32.55%) receiving and performance score of 162.75.

Average potential price target upside

of $37.67 (66.24%) on LNTH (LANTHEUS HOLDINGS).
of $19.4 (36.67%) on KYMR (KYMERA THERAPEUTICS).
of $17.29 (23.56%) on RYTM (RHYTHM PHARMACEUTICALS).

ABCL Abcellera Biologics GLPG Galapagos NV ADR IRWD Ironwood Pharmaceuticals KYMR Kymera Therapeutics LNTH Lantheus Holdings NRIX Nurix Therapeutics PRTC PureTech Health PLC PTGX Protagonist Therapeutics RAIN Rain Therapeutics RYTM Rhythm Pharmaceuticals STTK Shattuck Labs TRVI Trevi Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Faisal Khurshid (JEFFERIES)